Zhejiang Tianyu Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is OLMESARTAN MEDOXOMIL, with a corresponding US DMF Number 31888.
Remarkably, this DMF maintains an Active status since its submission on February 09, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 29, 2018, and payment made on April 10, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II